Jean-paul Behr

Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA.

Pharmaleads SA specializes in the detection, inhibition and modulation of proteases involved in human diseases. It designs and develops analgesic drugs with the aim to revolutionize the treatment of severe pain, with no side effects. The firm's products include high fluorescence substrates for proteases, substrates for BoNT quantification, and EzyBot, a field kit for botulinum toxin detection. The company was founded in 2000 by Bernard Roques and Marie-Claude Fournié-Zaluski and is headquartered in Paris, France.

Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore.

HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland.

Preem AB operates oil and gas refineries. It refines and sell fuels, heating and lubricating oil, as well as other products for companies and individuals. The company was founded in May 1996 and is headquartered in Stockholm, Sweden.

Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden.

The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA.

Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The company is based in Washington.

The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care.

The Natural History Museum operates an institution that collects and conserves artifacts and objects with artistic, historical and scientific importance. The company was founded on April 18, 1881 and is headquartered in London, the United Kingdom.

Academie des Technologies engages in the technology industry. The company was founded in December 2000 and is headquartered in Paris, France.

Compas SA wholesales chemical products. The company was founded on April, 19 1949 and is headquartered in Gueux, France.

Pearson Education Ltd. provides textbooks and professional learning books. Its offerings include computers, finance, business, mathematics and history. The company is headquartered in London, the United Kingdom.

Pancreta Bank SA provides commercial banking services. It engages in activities, which include issue of loans, guarantees and insurances, provision of techno-economic assistance and support for the development of its clients operations, deposits, and contracts for its members, with financial institutions or undertakings. The company was founded in 1993 and is headquartered in Heraklion, Greece.

NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden.

Cardiawave SA develops non-invasive medical device to treat a heart condition called aortic stenosis. The company was founded by Emmanuel Messas, Benjamin Bertrand, Mickaël Tanter, Mathieu Pernot and Mathias Fink on October 21, 2014 and is headquartered in Paris, France.

Greenerwave SAS develops software applications. It offers its products under the categories of wireless accessories, computer hardware and software, other consumer technology, smart home/appliances, smart home/appliances, wireless devices, telecommunications and infrastructure. The company was founded by Eric Labarre, Geoffroy Lerosey and Mathias Fink in 2015 and is headquartered in Nice, France.

UK Department for Business, Energy & Industrial Strategy operates as a government department which brings together responsibility for business, industrial strategy, and science and innovation with energy and climate change policy and merging the functions. The department is responsible for UK government policy in the following areas: business regulation and support, climate change policy in the United Kingdom, company law, competition, consumer affairs, corporate governance, energy, employment relations, export licensing, innovation, insolvency, intellectual property, outer space, postal affairs, regional and local economic development, science and research and trade. The company was founded on July 14, 2016 and is headquartered in London, the United Kingdom.

The Queen Elizabeth Prize for Engineering Foundation champions innovative engineering that benefits humanity. The non-profit company is based in London, UK. The British company awards the world's leading prize for engineers and engineering, which promotes excellence in the field. The QEPrize Ambassador Network brings together early career engineers from around the world to inspire the next generation.

eureKARE SA is a start-up studio that specializes in synthetic biology. The private company is based in Senningerberg, Luxembourg. The Luxembourger company identifies opportunities and needs in areas including health, environment, sustainability, and biomanufacturing. The company's scientists use engineering techniques to modify and improve biological components like living cells. The company catalyzes their innovations into successful businesses with access to funding and the right resources. The company was founded by Alexandre Mouradian, Rodolphe Besserve, Bénédicte Garbil, and Alexandre Mouradian has been the CEO since incorporation.

Meletios Therapeutics SAS is a French biotech company founded in 2020 by a team of high level scientists and experienced biotech managers. The company is based in Lyon, France. The company's aim is to fulfill the urgent and large unmet medical need for broad spectrum treatments against current and emerging viral infections. One of their first drug candidates has confirmed its broad-spectrum potential. Catherine Martre has been the CEO of the company since 2021.

eureKING SA is a special purpose acquisition company, which engages in acquiring one or more companies or operating businesses, through a merger, capital stock exchange, share purchase, asset acquisition, reorganization or similar transaction. It focuses on the completion of an initial business combination with one or several target businesses and companies with principal operations in the biomanufacturing sector. The company was founded by Michael Kloss, Hubert Olivier, Gerard Le Fur, Christophe Jean, Alexandre Mouradian, and Rodolphe Besserve and is headquartered in Paris, France.